MyAverix Finance
US · Healthcare
Arno Therapeutics (ARNI)
Biotechnology
Arno Therapeutics (ARNI) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ARNI
Arno Therapeutics (ARNI) — FAQ
What is ARNI's P/E ratio?
The price-to-earnings (P/E) ratio for Arno Therapeutics (ARNI) is 18.00 (data as of 2026-03-23).
Does Arno Therapeutics pay a dividend?
Dividend yield is not available in the current snapshot for Arno Therapeutics (ARNI). Check the MyAverix Finance app for the latest dividend data.
What sector is Arno Therapeutics in?
Arno Therapeutics (ARNI) is classified in the Healthcare sector (Biotechnology industry).
What exchange is ARNI listed on?
ARNI is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.